Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 250 | 0 | 0 | 70 | 833 |
| Gross Profit | 250 | N/A | N/A | 70 | 833 |
| Operating Expenses | 17,333 | 16,102 | 15,707 | 16,829 | 24,306 |
| Operating Income | -17,083 | -16,102 | -15,707 | -16,759 | -23,473 |
| Other Income | 965 | 1,148 | 1,218 | 1,100 | 1,265 |
| Pre-tax Income | -16,118 | -14,954 | -14,489 | -15,659 | -22,208 |
| Income Tax | N/A | N/A | N/A | N/A | -1,250 |
| Net Income Continuous | -16,118 | -14,954 | -14,489 | -15,659 | -20,958 |
| Net Income | $-16,118 | $-14,954 | $-14,489 | $-15,659 | $-20,958 |
| EPS Basic Total Ops | -2.50 | -2.30 | -2.30 | -2.40 | -3.40 |
| EPS Basic Continuous Ops | -2.50 | -2.35 | -2.30 | -2.47 | -3.36 |
| EPS Diluted Total Ops | -2.50 | -2.30 | -2.30 | -2.40 | -3.40 |
| EPS Diluted Continuous Ops | -2.50 | -2.35 | -2.30 | -2.47 | -3.36 |
| EBITDA(a) | $-16,567 | $-15,428 | $-14,871 | $-16,545 | $-18,012 |